Morgan Stanley MS
196.31
(0.01)
(0.01%)
as of 25 Sep
- Market cap
- $309.4B
- P/E
- 15.7×
Follow MS
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
16.14 | 17.20 | 14.73 | 16.70 |
P/S ratio |
2.14 | 2.34 | 2.08 | 2.52 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(74.95) | (115.95) | (36.19) | (118.26) | |
P/B ratio |
2.47 | 2.72 | 2.43 | 3.02 | |
Price to Tangible BV |
3.18 | 3.49 | 3.11 | 3.83 | |
EV/Sales |
2.03 | 2.04 | 1.71 | 1.91 | |
EV/EBITDA |
3.20 | 3.23 | 2.71 | 3.03 | |
EV/Operating CF |
(64.37) | (13.67) | (209.18) | (15.81) | |
EV/FCF |
(35.10) | (11.76) | (53.54) | (13.26) | |
Quick Ratio |
0.79 | 0.81 | 0.77 | 0.79 | |
Current Ratio |
0.79 | 0.81 | 0.77 | 0.79 | |
Net Debt/EBITDA |
(0.63) | (1.84) | (2.24) | (3.62) | |
Debt/Assets |
24.30% | 24.57% | 23.50% | 23.44% | |
Debt/Equity |
2.99 | 3.10 | 3.22 | 3.34 | |
Asset Turnover |
0.09 | 0.09 | 0.09 | 0.09 | |
Operating CF/Net income |
(0.75) | (0.57) | (1.31) | (0.51) | |
Capex/Depreciation |
(0.53) | (0.62) | (1.06) | (0.68) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
32.06% | 32.82% | 33.44% | 31.78% | |
Intangible Assets out of Total Assets |
0.02 | 0.02 | 0.01 | 0.01 | |
Share Based Compensation of Revenue |
1.44% | 1.56% | 1.72% | 1.63% | |
Graham Net Nets |
(2.12) | (1.90) | (2.42) | (1.95) | |
Graham Number |
119.54 | 123.21 | 130.41 | 139.72 | |
Earnings Yield |
6.20% | 5.81% | 6.79% | 5.99% | |
Free Cash Flow Yield |
(2.70%) | (7.44%) | (1.54%) | (5.72%) | |
Revenue per Share |
19.85 | 19.05 | 21.24 | 22.18 | |
Operating CF per Share |
(2.12) | (1.53) | (4.55) | (1.77) | |
Capex per Share |
(0.45) | (0.45) | (0.48) | (0.53) | |
Free Cash Flow per Share |
(2.57) | (1.98) | (5.03) | (2.29) | |
Cash per Share |
219.34 | 243.87 | 267.12 | 303.09 | |
Shareholders Equity per Share |
70.69 | 71.57 | 73.92 | 75.57 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
70.69 | 71.57 | 73.92 | 75.57 | |
Free Cash Flow |
(4,045.00) | (3,119.00) | (7,852.00) | (3,566.00) | |
Working Capital |
(196,938.00) | (182,023.00) | (250,974.00) | (240,667.00) | |
Capital Expenditures |
(713.00) | (709.00) | (754.00) | (819.00) | |
Net Current Asset Value |
(528,617.00) | (530,958.00) | (622,542.00) | (633,223.00) | |
EV/EBIT |
3.43 | 3.45 | 2.87 | 3.20 | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 | |
Net Profit Margin |
14.27% | 14.17% | 16.32% | 15.77% | |
Price to Operating Income |
3.62 | 3.94 | 3.49 | 4.22 | |
| Other line items | |||||
Average Receivables |
351,405.50 | 358,562.50 | 383,784.50 | 404,840.50 | |
Average Payables |
221,518.00 | 201,228.50 | 230,510.00 | 247,207.50 | |
Average Assets |
1,311,416.50 | 1,317,670.50 | 1,440,857.00 | 1,514,463.50 | |
Average Common Equity |
98,111.00 | 99,290.00 | 101,865.50 | 103,605.00 |
Columns are period end dates